These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1700858)

  • 61. CSF monoamine metabolites of depressed patients during illness and after recovery.
    Träskman-Bendz L; Asberg M; Bertilsson L; Thorén P
    Acta Psychiatr Scand; 1984 Apr; 69(4):333-42. PubMed ID: 6202099
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impaired neuropsychological functioning in Tourette's syndrome subjects with co-occurring obsessive-compulsive and attention deficit symptoms.
    de Groot CM; Yeates KO; Baker GB; Bornstein RA
    J Neuropsychiatry Clin Neurosci; 1997; 9(2):267-72. PubMed ID: 9144107
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Further evidence for co-segregation between pediatric obsessive compulsive disorder and attention deficit hyperactivity disorder: a familial risk analysis.
    Geller D; Petty C; Vivas F; Johnson J; Pauls D; Biederman J
    Biol Psychiatry; 2007 Jun; 61(12):1388-94. PubMed ID: 17241617
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients.
    Mann JJ; Malone KM
    Biol Psychiatry; 1997 Jan; 41(2):162-71. PubMed ID: 9018386
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Sociodemographic characteristics and mental disorders in children and adolescents psychiatric outpatient clinic children of Medellin].
    Ricardo-Ramírez C; Álvarez-Gómez M; Rodríguez-Gázquez Mde L
    Rev Colomb Psiquiatr; 2015; 44(2):115-20. PubMed ID: 26578334
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects.
    Fossey MD; Lydiard RB; Ballenger JC; Laraia MT; Bissette G; Nemeroff CB
    Biol Psychiatry; 1996 Apr; 39(8):703-7. PubMed ID: 8731457
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genetic and environmental contributions to the Child Behavior Checklist Obsessive-Compulsive Scale: a cross-cultural twin study.
    Hudziak JJ; Van Beijsterveldt CE; Althoff RR; Stanger C; Rettew DC; Nelson EC; Todd RD; Bartels M; Boomsma DI
    Arch Gen Psychiatry; 2004 Jun; 61(6):608-16. PubMed ID: 15184240
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Brain-derived neurotrophic factor V66M polymorphism in childhood-onset obsessive-compulsive disorder.
    Mössner R; Walitza S; Lesch KP; Geller F; Barth N; Remschmidt H; Hahn F; Herpertz-Dahlmann B; Fleischhaker C; Schulz E; Warnke A; Hinney A; Wewetzer C
    Int J Neuropsychopharmacol; 2005 Mar; 8(1):133-6. PubMed ID: 15638951
    [No Abstract]   [Full Text] [Related]  

  • 69. In this issue/Abstract thinking: Prenatal environment and mental health outcomes.
    Rettew DC
    J Am Acad Child Adolesc Psychiatry; 2008 Oct; 47(10):1101-2. PubMed ID: 20566185
    [No Abstract]   [Full Text] [Related]  

  • 70. Cruelty to animals and CSF 5HIAA.
    Kruesi MJ
    Psychiatry Res; 1989 Apr; 28(1):115-6. PubMed ID: 2472643
    [No Abstract]   [Full Text] [Related]  

  • 71. Indoleamines and affective disorders.
    Coppen A
    J Psychiatr Res; 1972 Sep; 9(3):163-71. PubMed ID: 5083172
    [No Abstract]   [Full Text] [Related]  

  • 72. CSF 5-HIAA and family history of psychiatric disorder.
    Traskman-Bendz L
    Am J Psychiatry; 1983 Sep; 140(9):1257. PubMed ID: 6193715
    [No Abstract]   [Full Text] [Related]  

  • 73. Serotonin and externalizing behavior in young children.
    Clarke RA; Murphy DL; Constantino JN
    Psychiatry Res; 1999 Apr; 86(1):29-40. PubMed ID: 10359480
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lack of Evidence for a Relationship Between the Hypothalamus-Pituitary-Adrenal and the Hypothalamus-Pituitary-Thyroid Axis in Adolescent Depression.
    Hirtz R; Libuda L; Hinney A; Föcker M; Bühlmeier J; Antel J; Holterhus PM; Kulle A; Kiewert C; Hebebrand J; Grasemann C
    Front Endocrinol (Lausanne); 2021; 12():662243. PubMed ID: 34108936
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lack of seasonal variation in pediatric lumbar cerebrospinal fluid neurotransmitter metabolite concentrations.
    Swedo SE; Kruesi MJ; Leonard HL; Hamburger SD; Cheslow DL; Stipetic M; Potter WZ
    Acta Psychiatr Scand; 1989 Dec; 80(6):644-9. PubMed ID: 2482656
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents.
    Kruesi MJ; Rapoport JL; Hamburger S; Hibbs E; Potter WZ; Lenane M; Brown GL
    Arch Gen Psychiatry; 1990 May; 47(5):419-26. PubMed ID: 1691910
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Concentration gradient of CSF monoamine metabolites in children and adolescents.
    Kruesi MJ; Swedo SE; Hamburger SD; Potter WZ; Rapoport JL
    Biol Psychiatry; 1988 Sep; 24(5):507-14. PubMed ID: 2458775
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine.
    Altemus M; Swedo SE; Leonard HL; Richter D; Rubinow DR; Potter WZ; Rapoport JL
    Arch Gen Psychiatry; 1994 Oct; 51(10):794-803. PubMed ID: 7524463
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CSF somatostatin in childhood psychiatric disorders: a preliminary investigation.
    Kruesi MJ; Swedo S; Leonard H; Rubinow DR; Rapoport JL
    Psychiatry Res; 1990 Sep; 33(3):277-84. PubMed ID: 1700858
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.